FEN1 and glioma: In our panel of two glioma cell lines, M059K and U251 cells, we observed that FEN1 deficiency significantly and consistently reversed resistance to TMZ, cisplatin and MMS, as indicated by cell viability and survival analyses (Fig. S1b-k).